23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial-Reference-Cited by-同舟云学术

23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

Published:2000-06 Issue:9221 Volume:355 Page:2106-2111
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

French N,Nakiyingi J,Carpenter LM,Lugada E,Watera C,Moi K,Moore M,Antvelink D,Mulder D,Janoff EN,Whitworth J,Gilks CF

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya;Gilks;Lancet,1996

2. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure;Simberkoff;Am Rev Respir Dis,1984

3. Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus;Garcia;Arch Intern Med,1992

4. Recommendations of the immunization practices advisory committee on pneumococcal polysaccharide vaccine;MMWR,1989

5. Immunisation Against Infectious Diseases,1992

Cited by 410 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Microbial Determinants of Upper Respiratory Colonization With Streptococcus pneumoniae and Native Microbiota in People With Human Immunodeficiency Virus Type 1 and Control Adults;The Journal of Infectious Diseases;2024-05-08

2. Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults;Nature Immunology;2024-01-05

3. Experimental pneumococcal carriage in people living with HIV in Malawi: the first controlled human infection model in a key at-risk population;Wellcome Open Research;2024-01-03

4. Clinical Features and Management of HIV/AIDS in Adults;Manson's Tropical Diseases;2024

5. Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023;MMWR. Recommendations and Reports;2023-09-08